EGFRvIII inhibitor

DRUG CLASS:

News alerts, weekly reports and conference planners

Related drugs:

‹

›

EGFRvIII mutation	Astrocytoma	EGFRvIII mutation	Astrocytoma	WSD0922 Sensitive: C3 – Early Trials WSD0922 Sensitive : C3	WSD0922 Sensitive: C3 – Early Trials WSD0922 Sensitive : C3
EGFRvIII expression	Glioblastoma	EGFRvIII expression	Glioblastoma	Undisclosed EGFRvIII-targeted alpha therapy Sensitive: D – Preclinical Undisclosed EGFRvIII-targeted alpha therapy Sensitive : D	Undisclosed EGFRvIII-targeted alpha therapy Sensitive: D – Preclinical Undisclosed EGFRvIII-targeted alpha therapy Sensitive : D

Associations(2)